Ascendis Pharma A (ASND) Net Margin (2014 - 2026)
Ascendis Pharma A's Net Margin came in at 61.00% for the quarter ended Jun 30, 2026, up 112.34 percentage points from -51.33% a year earlier but down 194.20 percentage points from the prior quarter.
Ascendis Pharma A (ASND) Net Margin (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ascendis Pharma A reported Net Margin of 71.01%, up 134.89 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at -31.67%, up 61.51 percentage points from the prior year.
- Net Margin has increased in each of the last five years, with a five-year change of +5993.86 percentage points (years ended Dec 2020 to Dec 2025).
- Going back by year, Net Margin was -93.17% in the year ended Dec 31, 2024 (+87.33 pp), -180.51% in the year ended Dec 31, 2023 (+959.12 pp), -1139.63% in the year ended Dec 31, 2022 (+3791.93 pp) and -4931.56% in the year ended Dec 31, 2021 (+1093.97 pp).
- The five-year range for quarterly Net Margin is -7219.05% (the quarter ended Sep 30, 2021) to 255.21% (the quarter ended Mar 31, 2026).
- Year-over-year, Net Margin has increased for eight consecutive quarters, with an average year-over-year change of +143.82 percentage points over the last eight quarters.
- The fastest year-over-year change in Net Margin over five years came in the quarter ended Jun 30, 2022 (a gain of 11828.03 percentage points), and the weakest in the quarter ended Sep 30, 2021 (a drop of 2803.34 percentage points).
- Business Quant data shows ASND's Net Margin at 255.21% (quarter ended Mar 31, 2026), -13.56% (quarter ended Dec 31, 2025) and -28.55% (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Ascendis Pharma A | 14.26 Bn | 10.50 Bn | 362.22 Mn | 61.00% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61.00% |
| Mar 31, 2026 | 255.21% |
| Dec 31, 2025 | -13.56% |
| Sep 30, 2025 | -28.55% |
| Jun 30, 2025 | -51.33% |
| Mar 31, 2025 | -93.73% |
| Dec 31, 2024 | -22.12% |
| Sep 30, 2024 | -171.52% |
| Jun 30, 2024 | -373.42% |
| Mar 31, 2024 | -136.65% |
| Dec 31, 2023 | -28.70% |
| Sep 30, 2023 | -337.73% |
| Jun 30, 2023 | -256.23% |
| Mar 31, 2023 | -330.21% |
| Dec 31, 2022 | -905.96% |
| Sep 30, 2022 | -1,105.00% |
| Jun 30, 2022 | -1,320.11% |
| Mar 31, 2022 | -1,837.99% |
| Dec 31, 2021 | -123.14% |
| Sep 30, 2021 | -7,219.05% |
Ascendis Pharma A Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();